BSX
Boston Scientific Corp
43.90$
-1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.6% | +3.5% | +6.8% | +2.2% | +8.4% | +2.2% | +8.5% | +0.1% | +4.4% | -1.6% | +4.6% | – | |
| – | +3.9% | +4.2% | +4.3% | +1.7% | +21.1% | -9.4% | -4.4% | -7.0% | -11.5% | +18.0% | +0.3% | – | |
| – | +6.7% | +3.1% | +8.4% | +2.4% | +0.9% | +10.4% | +16.1% | +3.4% | +11.2% | -8.2% | +6.5% | – | |
| – | +2.0% | +0.8% | +4.6% | +6.3% | +13.0% | -3.7% | +18.7% | -2.3% | +10.7% | -9.3% | +7.4% | – | |
| – | +11.0% | -1.1% | +6.0% | +8.0% | +3.2% | -0.9% | +7.5% | +1.5% | +5.3% | -2.9% | +1.2% | – | |
| – | +9.0% | -0.8% | +5.6% | +7.4% | +5.5% | -1.3% | +26.8% | -4.3% | +9.6% | -7.0% | +5.1% | – | |
| – | +0.0% | +15.4% | +16.0% | -9.8% | -12.6% | +52.1% | -8.6% | +28.2% | +14.9% | -11.1% | +9.9% | – | |
| – | +0.0% | +7.5% | +12.5% | +2.5% | +67.5% | -37.4% | +3.4% | -3.3% | +3.4% | +0.0% | +6.7% | – | |
| – | -17.1% | +20.4% | -30.9% | +59.0% | -12.4% | +37.6% | +16.9% | -0.2% | -25.5% | +66.0% | -8.8% | – | |
| – | -99.0% | +11,400.0% | -14.8% | +104.1% | -88.5% | +478.3% | +9.8% | +25.3% | -83.1% | -667.7% | – | – | |
| – | +0.0% | -2.0% | -34.4% | +44.8% | +20.7% | +19.1% | +17.7% | -4.8% | -11.5% | +100.1% | -32.2% | – | |
| – | -9.3% | +11.2% | -17.5% | +30.3% | +1.2% | +13.6% | +12.3% | +0.1% | -15.6% | +38.8% | -13.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.